Safety factor at the neuromuscular junction

Progress in Neurobiology

Volumn 64, Issue 4, 2001, Pages 393-429

  Wood, Sarah J ^a   R Slater, Clarke ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINERGIC RECEPTOR;

ADRENERGIC TRANSMISSION; AUTOIMMUNE DISEASE; BOTULISM; CHOLINERGIC TRANSMISSION; EATON LAMBERT SYNDROME; FROG; GUILLAIN BARRE SYNDROME; HUMAN; MUSCLE ACTION POTENTIAL; MUSCLE CELL; MYASTHENIA GRAVIS; MYOKYMIA; NEUROMUSCULAR JUNCTION DISORDER; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PLASTICITY; POSTSYNAPTIC INHIBITION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; REVIEW; SAFETY; SPECIES DIFFERENCE; SYNAPTOGENESIS;

ACTION POTENTIALS; ANIMALS; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMANS; MUSCLE FIBERS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR JUNCTION DISEASES; PRESYNAPTIC TERMINALS; RECEPTORS, CHOLINERGIC; SCHWANN CELLS; SYNAPTIC VESICLES;

EID: 0035084963     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(00)00055-1     Document Type: Review

References (225)

1. Temperature and synaptic efficacy in frog skeletal muscle
2. Sodium currents in mammalian muscle
3. Rapid and reversible effects of activity on acetylcholine receptor density at the neuromuscular junction in vivo
4. Effect of exercise on physiological age-related change at mouse neuromuscular junctions
5. Effects of endurance exercise on the morphology of mouse neuromuscular junctions during ageing
6. Nerve terminal morphology in C57BL/6NNia mice at different ages
7. Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic function
8. Morphometric analysis of human neuromuscular junction in different ages
9. Presynaptic calcium signals during neurotransmitter release: Detection with fluorescent indicators and other calcium chelators
10. Neuromuscular junctions shrink and expand as muscle fiber size is manipulated: In vivo observations in the androgen-sensitive bulbocavernosus muscle of mice
11. Neuromuscular transmission and correlative morphology in young and old mice
12. Sprouting and degeneration of mammalian motor axons in normal and de-afferentated skeletal muscle
13. Transversely cut diaphragm preparations from rat
14. Na channels in skeletal muscle concentrated near the neuromuscular junction
15. Congenital myasthenic syndromes. Studies of the AChR and other candidate genes
16. The immunocytochemical localization of N-acetylaspartyl glutamate, its hydrolysing enzyme NAALADase and the NMDAR-1 receptor at a vertebrate neuromuscular junction
17. Increased sodium conductance in the synaptic region of rat skeletal muscle fibres
18. The distribution of β-bungarotoxin binding sites on mammalian skeletal muscle developing in vivo
19. Spatial relationships of utrophin, dystrophin dystroglycan and β-spectrin to acetylcholine receptor clusters during postnatal maturation of the rat neuromuscular junction
20. Central and peripheral fatigue in sustained maximum voluntary contractions of human quadriceps muscle
21. The absence of neuromuscular transmission failure in sustained maximal voluntary contractions
22. Disorders of neuromuscular junction ion channels
23. Autoradiographic localization of voltage-dependent sodium channels on the mouse neuromuscular junction using 125I-alpha scorpion toxin. II. Sodium distribution on postsynaptic membranes
24. Ephedrine blocks wild-type and long-lived mutant acetylcholine receptor channels
25. Feedback control of transmitter release at the neuromuscular junction
26. The end-plate potential in mammalian muscle
27. + currents in mouse motor nerve terminals by tetrodotoxin mu-conotoxin and reduced external sodium
28. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice
29. Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals
30. Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions
31. Synaptic vesicle biogenesis, docking and fusion: A molecular description
32. Ion-channel defects and aberrant excitability in myotonia and periodic paralysis
33. Aging rat neuromuscular junctions: A morphometric study of cholinesterase-stained whole mounts and ultrastructure
34. Cellular and molecular biology of voltage-gated sodium channels
35. Vesicle hypothesis of the release of quanta of acetylcholine
36. Effects of chronic treatment with various neuromuscular blocking agents on the number and distribution of acetylcholine receptors in the rat diaphragm
37. Alterations in synaptic strength preceding axon withdrawal
38. Motor end plate structure
39. Données ultrastructurales et cytochimiques sur le méchanisme de libération de l'acétylcholine dans la transmission synaptique
40. Conus geographus toxins that discriminate between neuronal and muscle sodium channels
41. On the release of transmitter at normal myasthenia gravis and myasthenic syndrome affected human end-plates
42. 5-Hydroxytryptamine in the phrenic nerve diaphragm: Evidence for existence and release
43. Genetic analysis of synaptic development and plasticity: Homeostatic regulation of synaptic efficacy
44. Quantal components of the end-plate potential
45. Development of neuromuscular junctions in rat embryos
46. The effects of exercise training of different intensities on neuromuscular junction morphology
47. A study of foetal and new-born rat muscle fibres
48. Electromyography and electric stimulation of nerve in diseases with motor units. Observations on myasthenic syndrome associated with malignant tumors
49. Studies of excitable membranes. II. A comparison of specializations at neuromuscular junctions and nonjunctional sarcolemmas of mammalian fast and slow twitch muscle fibers
50. An electrophysiological investigation of neuromuscular transmission in myasthenia gravis
51. A quantitative study of end-plate potentials in isolated human muscle
52. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes
53. Myasthenic syndromes
54. The neuromuscular junction
55. Recently recognized congenital myasthenic syndromes: (a) end- plate acetylcholine (ach) esterase deficiency (b) putative abnormality of the ach induced ion channel (c) putative defect of ach resynthesis or mobilization-clinical features ultrastructure and cytochemistry
56. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel
57. Congenital myasthenic syndromes: Recent advances
58. Newly recognized congenital myasthenic syndromes: I. Congenital paucity of synaptic vesicles and reduced quantal release. II. high-conductance fast-channel syndrome. III. abnormal acetylcholine receptor (achr) interaction with acetylcholine. IV. achr deficiency and short channel-open time
59. Scanning and light microscopic study of age changes at a neuromuscular junction in the mouse
60. Ultrastructural studies of young and old mouse neuromuscular junctions
61. An analysis of the end-plate potential recorded with an intra-cellular electrode
62. Congenital myasthenia: A clinical and in vitro study of 11 cases
63. Ephedrine in the treatment of congenital myasthenic syndrome
64. Genetics of synaptic vesicle function: Toward the complete functional anatomy of an organelle
65. The nature of the presynaptic effect of (+)-tubocurarine at the mouse neuromuscular junction
66. + channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and 43 kd protein
67. Potentiation of neurotransmitter release by activation of presynaptic glutamate receptors at developing neuromuscular synapses of Xenopus
68. Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor
69. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones
70. Paucity and disorganization of presynaptic membrane active zones in the Lambert-Eaton myasthenic syndrome
71. Differences in neuromuscular transmission in red and white muscles
72. ATP and adenosine inhibit transmitter release at the frog neuromuscular junction through distinct presynaptic receptors
73. The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat
74. Transmission of impulses from nerve to muscle
75. Change of statistical parameters of transmitter release during various kinetic tests in unparalysed voltage-clamped rat diaphragm
76. Presynaptic action of curare
77. Voltage clamping of unparalysed cut rat diaphragm for study of transmitter release
78. Decrease of quantal size and quantal content during tetanic stimulation detected by focal recording
79. Geographutoxin-sensitive and insensitive sodium currents in mouse skeletal muscle developing in situ
80. Dynamics of nerve-muscle interaction in developing and mature neuromuscular junctions
81. Physiological regulation of synaptic effectiveness at frog neuromuscular junctions
82. Differences in the localization of the postsynaptic nitric oxide synthase I and acetylcholinesterase suggest a heterogeneity of neuromuscular junctions in rat and mouse skeletal muscles
83. Immunocytochemical localization of the mammalian voltage-dependent sodium channel using polyclonal antibodies against the purified protein
84. Autoreceptor-mediated purinergic and cholinergic inhibition of motor nerve terminal calcium currents in the rat
85. The relationship between end-plate size and transmitter release in normal and dystrophic muscles of the mouse
86. Post-synaptic potentiation: Interaction between quanta of acetylcholine at the skeletal neuromuscular synapse
87. Firing patterns of motor units in normal rats
88. Purinoceptors in neuromuscular transmission
89. Effects of aging and physical training on the neuromuscular junction of the mouse
90. Development of innervation of skeletal muscle fibres in man: Relation to acetylcholine receptors
91. Structural changes after transmitter release at the frog neuromuscular junction
92. Functional changes in frog neuromuscular junctions studied with freeze-fracture
93. Synapsins as regulators of neurotransmitter release
94. Presynaptic regulation of the release of acetylcholine by 5-hydroxytryptamine
95. The dual effect of membrane potential on sodium conductance in the giant axon of Loligo
96. The electrical constants of a crustacean nerve fibre
97. Evaluation of intrinsic modulation of synaptic transmission by ATP in mouse fast twitch muscle
98. Adenosine 5′-triphosphate activates acetylcholine receptor channels in cultured Xenopus myotomal muscle cells
99. Counting quanta: Direct measurements of transmitter release at a central synapse
100. The perinatal reorganization of the innervation of skeletal muscle in mammals
101. Embryonic acetylcholine receptors guarantee spontaneous contractions in rat developing muscle
102. Guanidine and neuromuscular transmission. II. Effect on transmitter release in response to repetitive nerve stimulation
103. The binding of acetylcholine to receptors and its removal from the synaptic cleft
104. On the factors which determine the amplitude of the 'miniature end-plate potential
105. The fine structure of motor endplate morphogenesis
106. The effect of age on neuromuscular transmission
107. Progression of age changes in synaptic transmission at mouse neuromuscular junctions
108. Morphological aspects of the elimination of polyneuronal innervation of skeletal muscle fibres in newborn rats
109. The number of transmitter molecules in a quantum: An estimate from iontophoretic application of acetylcholine at the neuromuscular synapse
110. Correlation between nerve terminal size and transmitter release at the neuromuscular junction of the frog
111. Autoimmune aetiology for myasthenic (eaton-lambert) syndrome
112. Junctional transmission in fast- and slow-twitch mammalian motor units
113. Visualization of neuromuscular junctions over periods of several months in living mice
114. Current therapy of the Lambert-Eaton myasthenic syndrome
115. Aggregation of sodium channels during development and maturation of the neuromuscular junction
116. Structure and function of the neuromuscular junction in young adult mdx mice
117. Neuromuscular transmission
118. The effect of voltage on the time course of end-plate currents
119. The effect of (+)-tubocuarine on neuromuscular transmission during repetitive stimulation in the rat mouse and frog
120. A further study of the statistical composition of the end-plate potential
121. Quantal nature of synaptic transmission
122. The effect of membrane capacitance on non-linear summation of synaptic potentials
123. Amplification of neuromuscular transmission by postjunctional folds
124. Anconeus muscle: A human muscle preparation suitable for in- vitro microelectrode studies
125. Fine structural distribution of acetylcholine receptors at developing mouse neuromuscular junctions
126. The statistics of transmitter release at chemical synapses
127. Non-linear summation of end-plate potentials in the frog and mouse
128. Bungarotoxin enhances transmitter 'released at the neuromuscuar junction'
129. Na channel density in extrajunctional sarcolemma of fast and slow twitch mouse skeletal muscle fibres: Functional implications and plasticity after fast motoneuron transplantation to a slow muscle
130. Fast and slow twitch skeletal muscle fibres differ in their distribution of Na channels near the endplate
131. Discrimination of muscle and neuronal Na-channel subtypes by binding competition between [3H]saxitoxin and mu-conotoxins
132. The mechanism of action of tetanus and botulinum neurotoxins
133. Synaptic vesicle abnormality in familial infantile myasthenia
134. ATP activates junctional and extrajunctional acetylcholine receptor channels in isolated adult-rat muscle-fibers
135. Sodium currents in smooth muscle cells freshly isolated from stomach fundus of the rat and ureter of the guinea-pig
136. Autoimmune neuromyotonia (Isaacs' syndrome): An antibody-mediated potassium channelopathy
137. Age changes of motor innervation and acetylcholine receptor distribution on human skeletal muscle fibres
138. Structure of motor endplates in the different fiber types of vertebrate skeletal muscles
139. Human acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the assymetric enzyme
140. Accumulation of NO synthase (type-I) at the neuromuscular junction in adult mice
141. The ultrastructure of the neuromuscular junctions of mammalian red, white and intermediate skeletal muscle fibers
142. The case for adaptability of the neuromuscular junction to endurance exercise training
143. Autoreceptors membrane potential and the regulation of transmitter release
144. The margin of safety of neuromuscular transmission
145. Neuromuscular blocking agents
146. Involvement of protein kinases in the upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats
147. Miller Fisher anti-GQ1b antibodies: Alpha-latrotoxin-like effects on motor end plates
148. Acetylcholine release in myasthenia gravis: Regulation at single end-plate level
149. Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats
150. Age-related remodeling of neuromuscular junctions on type-identified diaphragm fibers
151. Electrophysiological analysis of transmission at the skeletal neuromuscular junction
152. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings
153. Synaptic vesicle dynamics in rat fast and slow motor nerve terminals
154. Purinergic regulation of acetylcholine release
155. On the role inactivation and origin of engogenous adenosine at the frog neuromuscular junction
156. The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions
157. Serum factor in Miller-Fisher variant of Guillain-Barre syndrome and neurotransmitter release
158. Modulation of synaptic efficacy and synaptic depression by glial cells at the frog neuromuscular junction
159. Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses
160. Calcium channels and calcium-gated potassium channels at the frog neuromuscular junction
161. Functional colocalization of calcium and calcium-gated potassium channels in control of transmitter release
162. Calcium channels coupled to neurotransmitter release at neonatal rat neuromuscular junctions
163. The motor unit in cerebral palsy
164. Effects of chronic stress and exercise on age-related changes in end-plate architecture
165. + current density at and away from end plates on rat fast- and slow-twitch skeletal muscle fibers
166. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis
167. Comparison between slow sodium channel inactivation in rat slow- and fast-twitch muscle
168. + current densities and voltage dependence in human intercostal muscle fibres
169. Initiation of the propagated disturbance
170. Vertebrate neuromuscular junctions: General morphology, molecular organization, and functional consequences
171. Development of the neuromuscular junction: Genetic analysis in mice
172. Development of the vertebrate neuromuscular junction
173. Alternatively spliced sodium channel transcripts in brain and muscle
174. Alpha latrotoxin of black widow spider venom: An interesting neurotoxin and a tool for investigating the process of neurotransmitter release
175. Disorders of neuromuscular transmission due to natural environmental toxins
176. Ephedrine: Effects on neuromuscular transmission
177. Quantal ATP release from motor nerve endings and its role in neurally mediated depression
178. Pertussis toxin prevents the inhibitory effect of adenosine and unmasks adenosine-induced excitation at mammalian motor nerve endings
179. Prejunctional effects of the nictotinic ACh receptor agonist dimethylphenylpiperazinium at the rat neuromuscular junction
180. Postnatal maturation of nerve-muscle junctions in hindlimb muscles of the mouse
181. Postsynaptic folds and neuromusuclar disease
182. Structure and function of neuromuscular junctions in the vastus lateralis of man. A motor point biopsy study of two groups of patients
183. Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies
184. A myasthenic syndrome with congenital paucity of secondary synaptic clefts: CPSC syndrome
185. Sources of adenosine released during neuromuscular transmission in the rat
186. Adenosine derived from hydrolysis of presynaptically released ATP inhibits neuromuscular transmission in the rat
187. Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions
188. Use of mu-conotoxin GIIIA for the study of synaptic transmission at the frog neuromuscular junction
189. The calcium channel and the organization of the presynaptic transmitter release face
190. A comment on Martin's relation
191. Voltage gated sodium channels increase in density in junctional peri-junctional and non-junctional regions of developing rat muscle fibres
192. Active phase of frog's end-plate potential
193. Effects of calcium on the conductance change of the end-plate membrane during the action of acetylcholine
194. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals
195. The regulation of quantal size
196. Quantal acetylcholine release at the vertebrate neuromuscular junction
197. Synaptic current between neuromuscular junction folds
198. Congenital myasthenia: End-plate acetylcholine receptors and electrophysiology in five cases
199. Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis and in antibody-mediated arthrogryposis multiplex congenita
200. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome a paraneoplastic disorder
201. Genes at the junction - Candidates for congenital myasthenic syndromes
202. Evidence that catecholamines increase acetylcholine release from neuromuscular junctions through stimulation of α-1 adrenoceptors
203. Demonstration of glutamate-like immunoreactivity at rat neuromuscular junctions by quantitative electron microscopic immunocytochemistry
204. Postnatal development of rat motor nerve terminals
205. Species specific morphology of mammalian motor nerve terminals
206. Factors causing different properties at neuromuscular junctions in fast and slow rat skeletal muscles
207. Low quantal content of the endplate potential reduces safety factor for neuromuscular transmission in the diaphragm of the newborn rat
208. Functional differences between two classes of sodium channels in developing rat skeletal muscle
209. Sprouting and remodelling at the nerve-muscle junction
210. β-drenoceptor stimulation enhances transmitter output from the rat phrenic nerve
211. Autoimmunity and neurological disease: Antibody modulation of synaptic transmission
212. Regulation of single quantal efficacy at the snake neuromuscular junction
213. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside
214. Influence of presynaptic receptors on neuromuscular transmission in the rat
215. Morphological changes in the human end plate with age
216. An early stage in sodium channel clustering at developing rat neuromuscular junctions
217. Action potential generation in rat slow- and fast-twitch muscles
218. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles
219. Quantal content at neuromuscular junctions that lack postsynaptic folds
220. β-spectrin is co-localized with both voltage-gated sodium channels and ankyrinG at the rat neuromuscular junction
221. Sodium channel concentration is related to postsynaptic folding at the neuromuscular junction
222. Tetrodotoxin-resistant sodium channels
223. Redistribution of acetylcholine receptors on developing rat myotubes